Smart Inhalers Market 2024 - By Size, Share Analysis, Growth Trends And Forecasts To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Smart Inhalers Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $2.36 billion In 2028 At A CAGR Of 9.8% :

The smart inhalers market size has grown strongly in recent years. It will grow from $1.48 billion in 2023 to $1.62 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increased medical adherence, increasing focus on patient-centric healthcare, growing demand for connected healthcare devices.

The smart inhalers market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to rising prevalence of chronic respiratory diseases (CRDs), growing demand for home healthcare, increasing adoption of digital healthcare solutions. Major trends in the forecast period include technological advancements in smart inhalers, big data analytics, use of chip-on-sensors, advancements in sensor technology.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=14196&type=smp

Smart Inhalers Market Major Segments
The smart inhalers market covered in this report is segmented -

1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Hospitals, Homecare Settings, Other End-Users

Key Driver - The Impact Of Rising Chronic Respiratory Diseases On The Smart Inhalers Market

The rising prevalence of chronic respiratory diseases (CRDs) is expected to boost the growth of the smart inhaler market going forward. Chronic respiratory diseases (CRDs) encompass a range of long-term conditions that affect the airways and other structures of the lungs. Smart inhalers, by tracking usage and offering reminders for missed doses, manage chronic respiratory diseases such as asthma and COPD, ensuring consistent medication use for symptom control and prevention of exacerbations. For instance, in June 2023, according to reports shared by the Australian Institute of Health and Welfare, an Australia-based national agency, there was a rise in respiratory disease-related deaths from 43,031 in 2020 to 46,551 in 2021 in Australia. Furthermore, in September 2022, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, 11,255 new cases of RSV (respiratory syncytial virus) were recorded in 2021. Therefore, the rising prevalence of chronic respiratory diseases (CRDs) is driving the growth of the smart inhaler market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=14196&type=smp

Prominent Trend - Innovative Advancements in the Smart Inhaler Market

Major companies operating in the smart inhaler market are developing advanced technologies, such as digital respiratory health solutions, to meet larger customer bases, increase sales, and increase revenue. A digital respiratory health solution refers to a technological intervention or platform designed to address and manage respiratory health conditions through digital means. For instance, in February 2022, Aptar Pharma, a US-based pharma service company, launched the HeroTracker Sense, an add-on connected device and a distinctive digital respiratory health solution designed to transform standard metered-dose inhalers (MDIs) into smart connected healthcare devices. Specifically designed for patients worldwide grappling with chronic respiratory diseases like asthma, COPD, cystic fibrosis, and conditions resulting from COVID-19, this next-generation MDI add-on device focuses on improving patients' lives. By attaching to the canister of an MDI, HeroTracker Sense offers advanced features, including sensors to track inhalation coordination, flow rate, and duration. It provides information through an accompanying app, offering date and time stamps for medication reminders and environmental monitoring alerts such as temperature and humidity. The device aims to enhance patient adherence to prescribed therapies by enabling informed and compliant medication intake.

Smart Inhalers Market Players
Major companies operating in the smart inhalers market are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the smart inhalers market in 2023. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Smart Inhalers Market Report Structure
3. Smart Inhalers Market Trends And Strategies
4. Smart Inhalers Market - Macro Economic Scenario
5. Smart Inhalers Market Size And Growth
…..
27. Smart Inhalers Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.